Cargando…

A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein

Since the global outbreak of coronavirus disease 2019 (COVID-19), it has spread rapidly around the world. The nucleocapsid (N) protein is one of the most abundant SARS-CoV-2 proteins. Therefore, a sensitive and effective detection method for SARS-CoV-2 N protein is the focus of research. Here, we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Lirui, Du, Bin, Pei, Fubin, Hu, Wei, Feng, Shasha, Liu, Bing, Tong, Zhaoyang, Tan, Wenyuan, Mu, Xihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216089/
https://www.ncbi.nlm.nih.gov/pubmed/37232910
http://dx.doi.org/10.3390/bios13050549
_version_ 1785048215233495040
author Fan, Lirui
Du, Bin
Pei, Fubin
Hu, Wei
Feng, Shasha
Liu, Bing
Tong, Zhaoyang
Tan, Wenyuan
Mu, Xihui
author_facet Fan, Lirui
Du, Bin
Pei, Fubin
Hu, Wei
Feng, Shasha
Liu, Bing
Tong, Zhaoyang
Tan, Wenyuan
Mu, Xihui
author_sort Fan, Lirui
collection PubMed
description Since the global outbreak of coronavirus disease 2019 (COVID-19), it has spread rapidly around the world. The nucleocapsid (N) protein is one of the most abundant SARS-CoV-2 proteins. Therefore, a sensitive and effective detection method for SARS-CoV-2 N protein is the focus of research. Here, we developed a surface plasmon resonance (SPR) biosensor based on the dual signal-amplification strategy of Au@Ag@Au nanoparticles (NPs) and graphene oxide (GO). Additionally, a sandwich immunoassay was utilized to sensitively and efficiently detect SARS-CoV-2 N protein. On the one hand, Au@Ag@Au NPs have a high refractive index and the capability to electromagnetically couple with the plasma waves propagating on the surface of gold film, which are harnessed for amplifying the SPR response signal. On the other hand, GO, which has the large specific surface area and the abundant oxygen-containing functional groups, could provide unique light absorption bands that can enhance plasmonic coupling to further amplify the SPR response signal. The proposed biosensor could efficiently detect SARS-CoV-2 N protein for 15 min and the detection limit for SARS-CoV-2 N protein was 0.083 ng/mL, with a linear range of 0.1 ng/mL~1000 ng/mL. This novel method can meet the analytical requirements of artificial saliva simulated samples, and the developed biosensor had a good anti-interference capability.
format Online
Article
Text
id pubmed-10216089
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102160892023-05-27 A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein Fan, Lirui Du, Bin Pei, Fubin Hu, Wei Feng, Shasha Liu, Bing Tong, Zhaoyang Tan, Wenyuan Mu, Xihui Biosensors (Basel) Article Since the global outbreak of coronavirus disease 2019 (COVID-19), it has spread rapidly around the world. The nucleocapsid (N) protein is one of the most abundant SARS-CoV-2 proteins. Therefore, a sensitive and effective detection method for SARS-CoV-2 N protein is the focus of research. Here, we developed a surface plasmon resonance (SPR) biosensor based on the dual signal-amplification strategy of Au@Ag@Au nanoparticles (NPs) and graphene oxide (GO). Additionally, a sandwich immunoassay was utilized to sensitively and efficiently detect SARS-CoV-2 N protein. On the one hand, Au@Ag@Au NPs have a high refractive index and the capability to electromagnetically couple with the plasma waves propagating on the surface of gold film, which are harnessed for amplifying the SPR response signal. On the other hand, GO, which has the large specific surface area and the abundant oxygen-containing functional groups, could provide unique light absorption bands that can enhance plasmonic coupling to further amplify the SPR response signal. The proposed biosensor could efficiently detect SARS-CoV-2 N protein for 15 min and the detection limit for SARS-CoV-2 N protein was 0.083 ng/mL, with a linear range of 0.1 ng/mL~1000 ng/mL. This novel method can meet the analytical requirements of artificial saliva simulated samples, and the developed biosensor had a good anti-interference capability. MDPI 2023-05-15 /pmc/articles/PMC10216089/ /pubmed/37232910 http://dx.doi.org/10.3390/bios13050549 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fan, Lirui
Du, Bin
Pei, Fubin
Hu, Wei
Feng, Shasha
Liu, Bing
Tong, Zhaoyang
Tan, Wenyuan
Mu, Xihui
A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title_full A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title_fullStr A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title_full_unstemmed A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title_short A Novel SPR Immunosensor Based on Dual Signal Amplification Strategy for Detection of SARS-CoV-2 Nucleocapsid Protein
title_sort novel spr immunosensor based on dual signal amplification strategy for detection of sars-cov-2 nucleocapsid protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216089/
https://www.ncbi.nlm.nih.gov/pubmed/37232910
http://dx.doi.org/10.3390/bios13050549
work_keys_str_mv AT fanlirui anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT dubin anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT peifubin anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT huwei anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT fengshasha anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT liubing anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT tongzhaoyang anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT tanwenyuan anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT muxihui anovelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT fanlirui novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT dubin novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT peifubin novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT huwei novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT fengshasha novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT liubing novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT tongzhaoyang novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT tanwenyuan novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein
AT muxihui novelsprimmunosensorbasedondualsignalamplificationstrategyfordetectionofsarscov2nucleocapsidprotein